Results 271 to 280 of about 16,419,568 (354)

Vaccination coverage and serological follow-up in children with rheumatologic diseases: a retrospective single-centre study. [PDF]

Pediatr Rheumatol Online J
Grafas I, Pittet LF, Mejbri M, Blanchard-Rohner G.   +3 more
europepmc   +1 more source

Cardiovascular toxicity from immune checkpoint inhibitor therapy: an inflammatory continuum

British Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitor (ICI) therapy has markedly improved outcomes in advanced malignancies but has also revealed a distinct spectrum of cardiovascular immune‐related adverse events. Myocarditis represents the most severe manifestation, while non‐inflammatory left ventricular dysfunction and vascular inflammation have emerged as additional ...
Fabrice Reyes, Florian Buehning, Tobias Lerchner, Julia Vogel, Raluca I. Mincu, Matthias Totzeck, Tienush Rassaf, Lars Michel   +7 more
wiley   +1 more source

Dynamics of Anti-HBc Serology During Anti-CD20 Therapy: Incidence, Timing, and Predictors of Anti-HBc Seroclearance in a Retrospective Cohort. [PDF]

Medicina (Kaunas)
Eren F, Celik MA, Akduman R, Yasar M, Goktug MR, Ocakoglu G, Gurel S.   +6 more
europepmc   +1 more source

Arrhythmias associated with immune checkpoint inhibitor therapy—A clinical perspective

British Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitors (ICIs) have transformed cancer therapy but are associated with a growing spectrum of cardiovascular immune‐related adverse events. Among these, arrhythmias represent a rare yet potentially life‐threatening complication. ICI‐induced arrhythmias encompass a wide clinical spectrum, including atrial arrhythmias, conduction ...
Dong Wang, Melanie Ricke‐Hoch, David Duncker, Johann Bauersachs, Dominik Berliner   +4 more
wiley   +1 more source

Human Organoids in Infectious Disease Research: From Host-Pathogen Interactions to Vaccine Development. [PDF]

Vaccines (Basel)
Zielinska D, Fol M, Druszczynska M.
europepmc   +1 more source

Extracellular vesicles in pharmacology: Innovations in drug delivery and therapeutic applications in cancer

British Journal of Pharmacology, EarlyView.
Extracellular vesicles (EVs) are a diverse population of membrane nanoparticles secreted by nearly all cell types, playing a key role in intercellular communication by transferring bioactive macromolecular cargo. In cancer, EVs shape both the local tumour microenvironment and distant premetastatic niches.
Evangelia Pantazaka, Georgios Sivvas, Evangelia Papadimitriou, Constantinos M. Mikelis   +3 more
wiley   +1 more source

COVID-19 mRNA Vaccines as Antigen-Agnostic Immunomodulators: A Repurposing Perspective. [PDF]

Med Sci (Basel)
Minoretti P, Emanuele E.
europepmc   +1 more source

[Hepatitis B antigen].

Gaceta medica de Mexico, 1976
openaire   +1 more source

Long non‐coding RNAs at the crossroads of inflammation, cancer and angiogenesis: Molecular mechanisms and their potential as therapeutic targets

British Journal of Pharmacology, EarlyView.
Long non‐coding RNAs (lncRNAs), a broad class of non‐protein‐coding RNAs, are characterized as new regulators of gene expression at the epigenetic, transcriptional, and post‐transcriptional level. Thus, lncRNAs are involved in the regulation of physiological processes and the development of human diseases and cancer by modulating proinflammatory ...
Charlie Leboff, Pamela Calle‐Mendoza, Maria Hatziapostolou, Christos Polytarchou   +3 more
wiley   +1 more source

HBsAg decline and clearance with peg-IFN therapy added to nucleos(t)ide analogues: an individual participant data meta-analysis of prospective trials (PROSPER). [PDF]

Gut
Dongelmans EJ, Patmore LA, Lim SG, Bourliere M, Jiang S, Ganne-Carrie N, Brouwer WP, Feld JJ, Huang Y, Carrion JA, Broquetas T, Hu Q, Fung S, Carrat F, Zoulim F, Hansen BE, Xie Q, Janssen HLA, Sonneveld MJ.   +18 more
europepmc   +1 more source